榮科科技(300290.SZ):董事長樑榮辭職
格隆匯 9 月 30日丨榮科科技(300290.SZ)公佈,公司董事會於今日收到公司董事長樑榮的書面離職申請。樑榮因個人原因,申請辭去公司董事長、董事、董事會戰略委員會委員等職務,辭職後不再擔任公司任何職務。樑榮的原定任職期限為2019年4月3日至2022年4月2日。根據《公司法》、《公司章程》等有關規定,樑榮的辭職未導致公司董事會低於法定最低人數,其離職申請自送達董事會之日起生效。
樑榮的辭職不會影響公司董事會的正常運作。公司將按照法定程序儘快完成公司董事長的補選。在選舉產生新任董事長之前,由公司副董事長崔萬田代為履行董事長職責。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.